66 Recruiting Brain Metastases Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Brain Metastases
Related Conditions
Top Recruiting Brain Metastases Studies
Preop fSRS for Resectable Brain Metastases
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
📍 Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔Study Assessing QBS72S For Treating Brain Metastases
📍 Stanford Cancer Institute — Palo Alto, California
View Study & Checklist ➔A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Neurocognitive Decline in Patients With Brain Metastases
📍 University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases
📍 Duke University Health System — Durham, North Carolina
View Study & Checklist ➔Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)
📍 HonorHeath Scottsdale Osborn Medical Center — Phoenix, Arizona
View Study & Checklist ➔GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases
📍 BAPTIST ALLIANCE - MCI (Data Collection Only) — Miami, Florida
View Study & Checklist ➔Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Pembrolizumab In Central Nervous System Metastases
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Radiosurgery With or Without Whole Brain Radiation for Multiple Metastases
📍 Sunnybrook Odette Cancer Centre — Toronto, Ontario
View Study & Checklist ➔Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔FLT-PET / MRI Brain Mets
📍 University Health Network — Toronto, Ontario
View Study & Checklist ➔Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib
📍 University of California San Francisco — San Francisco, California
View Study & Checklist ➔IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases
📍 UF Health — Gainesville, Florida
View Study & Checklist ➔Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
📍 Miami Cancer Institute — Miami, Florida
View Study & Checklist ➔Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique
📍 Froedtert Hospital & the Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔Frameless Stereotactic Radiosurgery for Intact Brain Metastases
📍 University of Chicago — Chicago, Illinois
View Study & Checklist ➔Stereotactic Radiosurgery Dose Escalation for Brain Metastases
📍 Huntsman Cancer Institute — Salt Lake City, Utah
View Study & Checklist ➔NTS-WBRT in Brain Metastases
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial Metastasis Treated With (SRS)
📍 Sunnybrook Health Sciences Centre — Toronto, Ontario
View Study & Checklist ➔EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
📍 The University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔MeDex: No Perioperative Dexamethasone in Brain Metastases
📍 University of Louisville Hospital — Louisville, Kentucky
View Study & Checklist ➔Phase I Study of Fractionated Stereotactic Radiation Therapy
📍 Montefiore Medical Center — The Bronx, New York
View Study & Checklist ➔Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Feasibility of a Cognitive Stepped Care Program for Adults With Brain Metastases
📍 Princess Margaret Cancer Centre, University Health Network — Toronto, Ontario
View Study & Checklist ➔Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
📍 Miami Cancer Institute at Baptist Health South Florida — Miami, Florida
View Study & Checklist ➔MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
📍 University of North Carolina at Chapel Hill, Department of Radiation Oncology — Chapel Hill, North Carolina
View Study & Checklist ➔Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
📍 Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina
View Study & Checklist ➔Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
📍 University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona
View Study & Checklist ➔A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
📍 University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
📍 Arizona Cancer Center at UMC North/University Medical Center — Tucson, Arizona
View Study & Checklist ➔Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔REMASTer: REcurrent Brain Metastases After SRS Trial
📍 UCLA — Los Angeles, California
View Study & Checklist ➔Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)
📍 Medical University of South Carolina Hollings Cancer Center — Charleston, South Carolina
View Study & Checklist ➔Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
📍 University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center — Birmingham, Alabama
View Study & Checklist ➔